Abstract
At the beginning of 2020, coronavirus disease 2019 (COVID-19) spreads worldwide. Patients with ovarian cancer should be considered at high-risk of developing severe morbidity related to COVID-19. Most of them are diagnosed in advanced stages of disease, and they are fragile. Here, we evaluated the major impact of COVID-19 on patients with ovarian cancer, discussing the effect of the outbreak on medical and surgical treatment.
Keywords:
COVID-19; SARS-CoV; chemotherapy; ovarian cancer; surgery.
© 2020 Wiley Periodicals LLC.
MeSH terms
-
Betacoronavirus / isolation & purification
-
COVID-19
-
Coronavirus Infections / epidemiology
-
Coronavirus Infections / prevention & control*
-
Coronavirus Infections / transmission
-
Female
-
Gynecologic Surgical Procedures / methods
-
Gynecologic Surgical Procedures / standards
-
Humans
-
Infection Control / methods
-
Infection Control / standards
-
Infectious Disease Transmission, Patient-to-Professional / prevention & control
-
Laparoscopy / methods
-
Laparoscopy / standards
-
Ovarian Neoplasms / surgery*
-
Ovarian Neoplasms / virology
-
Pandemics / prevention & control*
-
Pneumonia, Viral / epidemiology
-
Pneumonia, Viral / prevention & control*
-
Pneumonia, Viral / transmission
-
SARS-CoV-2
-
Surgical Oncology / methods*
-
Surgical Oncology / standards